This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Acknowledgements
The author thanks Sabir Rassiwalla of Domain Associates for background research.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klausner, A. Biotech venture capital—it's not too late to be early. Nat Biotechnol 23, 417–418 (2005). https://doi.org/10.1038/nbt0405-417
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0405-417
This article is cited by
-
Shift toward early-stage deals favors biotechs
Nature Biotechnology (2006)
-
Early-stage exits: sometimes, less is more
Bioentrepreneur (2005)
-
Management potential
Nature (2005)